BIT
AXDX

BlackRock Institutional Trust’s Accelerate Diagnostics AXDX Stock Holding History

BlackRock Institutional Trust’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$13.5M Buy
64,935
+361
+0.6% +$85.7K ﹤0.01% 2224
2016
Q3 		$17.6M Buy
64,574
+1,468
+2% +$325K ﹤0.01% 1971
2016
Q2 		$9.08M Sell
63,106
-1,052
-2% -$141K ﹤0.01% 2348
2016
Q1 		$9.22M Buy
64,158
+7,616
+13% +$1.07M ﹤0.01% 2312
2015
Q4 		$12.2M Buy
56,542
+5,828
+11% +$1.06M ﹤0.01% 2201
2015
Q3 		$8.21M Buy
50,714
+8,100
+19% +$1.75M ﹤0.01% 2427
2015
Q2 		$11M Buy
42,614
+527
+1% +$126K ﹤0.01% 2347
2015
Q1 		$9.47M Buy
42,087
+12,954
+44% +$2.71M ﹤0.01% 2421
2014
Q4 		$5.59M Buy
29,133
+4,764
+20% +$1.02M ﹤0.01% 2682
2014
Q3 		$5.23M Sell
24,369
-3,296
-12% -$641K ﹤0.01% 2671
2014
Q2 		$7.19M Buy
27,665
+16,808
+155% +$3.67M ﹤0.01% 2617
2014
Q1 		$2.37M Buy
10,857
+94
+0.9% +$13.9K ﹤0.01% 3094
2013
Q4 		$1.31M Sell
10,763
-508
-5% -$67.9K ﹤0.01% 3311
2013
Q3 		$1.51M Buy
11,271
+1,156
+11% +$103K ﹤0.01% 3242
2013
Q2 		$821K Buy
+10,115
New +$751K ﹤0.01% 3380

Other funds holding AXDX

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
JMPWA
JP Morgan Private Wealth Advisors San Francisco, California $35B AUM 24.26% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return

BlackRock Institutional Trust's AXDX Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Accelerate Diagnostics (AXDX) stake by 0.56% in Q4 2016, buying an estimated $85.7K and bringing the position to 64,935 shares worth $13.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2224.

BlackRock Institutional Trust first reported a position in AXDX in Q2 2013 and has held it in 15 quarters since. The position peaked at $17.6M in Q3 2016. 109 funds tracked by Wall St. Rank hold AXDX as of Q4 2016.

  • BlackRock Institutional Trust held 64,935 shares of Accelerate Diagnostics worth $13.5M as of Q4 2016.
  • BlackRock Institutional Trust bought 361 Accelerate Diagnostics shares in Q4 2016, an estimated $85.7K.
  • Accelerate Diagnostics made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #2224 holding.
  • BlackRock Institutional Trust first reported a position in Accelerate Diagnostics in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Institutional Trust's Accelerate Diagnostics position peaked at $17.6M in Q3 2016.
  • 109 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.